Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene SILVER SPRING, Md., Aug. 7, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.